Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Dahan Michel Create: Alert

All | News | Filings
Date FiledTypeDescription
05/25/2023 4 Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 200,000 shares @ $0
Sold 95,478 shares @ $1.2229, valued at $116.8k
Granted 200,000 options to buy @ $0.41, valued at $82k
05/25/2023 144 Form 144 - Report of proposed sale of securities:
05/16/2023 4 Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 200,000 shares @ $0
03/03/2023 4 Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 8,058 shares @ $0.8775, valued at $7.1k
Sold 10,476 shares @ $0.8775, valued at $9.2k
Sold 1,878 shares @ $0.8775, valued at $1.6k
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/12/2019 4 Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Disposed/sold 11,909 shares @ $7.7, valued at $91.7k
03/05/2019 4 Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 65,000 shares @ $0
Granted 100,000 options to buy @ $7.28, valued at $728k
12/13/2018 4 Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Paid exercise price by delivering 23,385 shares @ $8.94, valued at $209.1k
03/02/2018 4 Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 19,400 shares @ $0
Granted 27,500 options to buy @ $14.3, valued at $393.3k
10/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/04/2017 4 Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 1,401 shares @ $9.1775, valued at $12.9k
02/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
10/04/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/06/2016 4 Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 1,402 shares @ $7.4665, valued at $10.5k
04/05/2016 4 Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 1,401 shares @ $9.41, valued at $13.2k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy